<p><strong> </strong><strong>Clinicians should stage unfavorable intermediate- and high-risk localized prostate cancer using either PSMA PET scan or a combination of bone scan and cross-sectional imaging.</strong><em><strong> (Strong Recommendation; Evidence Level: Grade B)</strong></em></p>